Overseas Clinical Trial Data Accepted for China Pharmaceutical Registration
On July 10th, 2018, the China National Medical Products Administration (NMPA) officially issued the Technical Guidelines for Accepting Overseas Clinical Trial Data of Drugs. With the release of this Guidelines, the qualified overseas clinical trial data can be directly used for pharmaceutical registration in China, which makes the simultaneous R&D work of new drugs feasible…